SEMINAR: Charles Gersbach, PhD (Duke University)
“Genome and Epigenome Editing with CRISPR/Cas9 Technologies for Gene Therapy, Cell Programming, and Functional Epigenomics”
“Genome and Epigenome Editing with CRISPR/Cas9 Technologies for Gene Therapy, Cell Programming, and Functional Epigenomics”